pharmaceutical
NHS to offer GP appointments via smartphone
November 6, 2017Medical Communications, Sales and Marketing GP at hand, NHS, biotech, drugs, pharma, pharmaceutical
It has been announced that I trial will begin in London offering the public GP consultations through their smartphone. The …
Novartis aims for CAR-T double-approval in Europe
November 6, 2017Sales and Marketing CAR-T, Gilead, Juno, Novartis, biotech, drugs, pharma, pharmaceutical
Just last week Novartis revealed it had applied to the FDA for a new indication in diffuse large B-cell lymphoma …
GSK’s R&D head to move on after shift in focus
November 3, 2017Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from …
Witty to lead way in fast-tracking medicine through UK system
November 3, 2017Medical Communications AAR, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …
Teva’s woes continue, as shares sink to 17-year low on Q3 results
November 2, 2017Medical Communications Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start …
Tissue Regenix promotes new CEO from within
November 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, tissue regenix
Just over two weeks ago, Tissue Regenix announced that its long-standing CEO, Antony Odell, would be leaving the company. It …
New test could determine womens’ risk of miscarriage or premature birth
November 2, 2017Research and Development biotech, drugs, pharma, pharmaceutical, pregnancy
Scientists in the US have reported findings suggesting that certain molecules in the blood are strongly associated with complications during …
Allergan ready to take a loss by selling Teva shares
November 2, 2017Sales and Marketing Allergan, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Allergan sold its generic business to Teva back in August 2016 for a sum of $33 billion and 100 million …
Novartis reveals the data behind its showdown with Gilead
November 1, 2017Research and Development CAR-T, Gilead, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical
Only yesterday it was revealed that Novartis had applied to the FDA in the same indication that Gilead’s treatment is …
Topas Therapeutics brings in new CMO
November 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Topas Therapeutics, biotech, drugs, pharma, pharmaceutical
Topas Therapeutics, a German company focused on developing novel therapeutics to treat immune-mediated and autoimmune diseases, announced that it has …
Roche’s Tecentriq approved for funding in UK in bladder cancer
November 1, 2017Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical
In a rare spot of good news for Tecentriq (atezolizumab), after a turbulent period, Roche’s drug has been given the …
CEO and President implicated as price-fixing probe widens
November 1, 2017Research and Development, Sales and Marketing Mylan, Teva, biotech, drugs, pharma, pharmaceutical
A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …
Cancer death rates 61% higher in poorer areas
November 1, 2017Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical
Figures released by NHS Scotland have revealed that the numbers of deaths from cancer are 67% higher in the poorest …
Collaboration in Biopharma
October 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dear Colleague,
NHS was crippled by “unsophisticated” cyber attack
October 27, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
Back in May of this year, the NHS was hit by a cyber attack that severely impacted at least 34% …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
